Sima S. Toussi
Pfizer (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Respiratory viral infections research, Autoimmune and Inflammatory Disorders Research, SARS-CoV-2 detection and testing
Most-Cited Works
- → Methamphetamine Inhibits Antigen Processing, Presentation, and Phagocytosis(2008)158 cited
- → Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir(2022)153 cited
- → Infections in Children and Adolescents With Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease Treated With Tumor Necrosis Factor- Inhibitors: Systematic Review of the Literature(2013)113 cited
- → Therapeutics for COVID-19(2023)104 cited
- → Targeted Killing of Virally Infected Cells by Radiolabeled Antibodies to Viral Proteins(2006)91 cited
- → (1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker forCandidaandAspergillusInfections of the Central Nervous System in Pediatric Patients(2015)76 cited
- → Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID‐19, in Subjects With Renal Impairment(2022)65 cited
- → Short Communication: Methamphetamine Treatment Increases in Vitro and in Vivo HIV Replication(2009)60 cited
- → The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis(2016)55 cited
- → Health Literacy and Adherence to Antiretroviral Therapy Among HIV-Infected Youth(2013)49 cited